Post-transplantation lymphoproliferative disease
نویسندگان
چکیده
منابع مشابه
Lymphoproliferative disease post-renal transplantation.
Psychosocial influences on mortality after myocardial infarction. suffering, morbidity and mortality of the patients N Engl J Med 1984; 311: 552–559 diminished. 9. Covinsky KE, Kahana E, Chin MH, Palmer RM, Fortinsky RH, Landefield CS. Depressive symptoms and 3-year mortality in older hospitalized patients. Ann Intern Med 1999; 130: 563–569 References 10. Kimmel PI, Weihs KL, Peterson RA. Survi...
متن کاملPost Transplant Lymphoproliferative Disorders After Liver Transplantation
Post-transplant lymphoproliferative disorder (PTLD) is a clearly recognized and potentially life threatening complication after solid organ or bone marrow transplantation. It comprises a spectrum of diseases ranging from infectious mononucleosis and lymphoid hyperplasia to highly aggressive lymphoma. The disease has increased clinical importance in view of the constantly rising number of organ ...
متن کاملPost-transplantation lymphoproliferative disorder with gastrointestinal involvement
Post-transplantation lymphoproliferative disorders (PTLDs) are lymphoid proliferations or lymphomas that are the second most common tumors in adult transplant recipients. Most cases of PTLD are attributed to Epstein-Barr virus, which induces B-cell proliferation and occurs in the setting of severe immunosuppression after solid organ or bone marrow transplantation. The disorder is seen in 1-3% o...
متن کاملPost-transplantation lymphoproliferative disorder in pediatric patient.
Immunosuppressive therapy for transplanted patients exposes them to a high risk of developing posttransplantation lymphoproliferative disorders (PTLD). We report the case of a child undergoing heart transplantation at seven months of age who developed PTLD at nine years of age, diagnosed by resection of a pulmonary nodule.
متن کاملPosttransplant Lymphoproliferative Disease after Lung Transplantation
Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral host immunity and permits Epstein-Barr viral (EBV) replication and transformation of B cells. Mechanistically, EBV survives due to latency, escape from cytotoxic T cell responses, and downregulation of host immunity to EBV. Clinical presentation of EBV may ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: QJM
سال: 1997
ISSN: 1460-2393
DOI: 10.1093/qjmed/90.8.497